Targeted therapy attacks cancer at its molecular core while sparing healthy cells. Discover the latest treatments.
Chemotherapy is aggressive. Targeted therapy is personalized, less toxic, and often more effective for ovarian cancer patients.
Drugs block cancer cells from repairing DNA and are highly effective in patients with BRCA mutations.
Faulty BRCA cells rely on PARP. Blocking PARP triggers cell death in cancer cells, preventing tumor growth.
Angiogenesis inhibitors block tumor blood vessels, starving cancer cells and preventing further growth.
Mainly used after chemotherapy for maintenance to prevent recurrence or to treat cancer that has returned.
Antibody Drug Conjugates deliver chemotherapy directly to cancer cells, increasing treatment precision and effectiveness.
Molecular profiling identifies tumor mutations, enabling doctors to choose the most effective targeted therapy.